NCT06959654View on ClinicalTrials.gov

The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 15, 2028

Conditions

Ulcerative Colitis Disease Patients and Normal Patients

Interventions

DIAGNOSTIC_TEST

ELISA test

ELISA test to evaulate serum oncostatin M and galactin 3 in two group of patientsL

All Listed Sponsors

lead

Sohag University

OTHER